Posted by & filed under Company Analysis, Financial analysis, Growth & Valuation, Industry Analysis, Management Issues, Personal Finance.

Description: Health-care giant Johnson & Johnson is splitting off its consumer division, following in the footsteps of other big drugmakers that have moved to focus on the more-profitable pharmaceutical market.

Source: – video report

Date: Nov 12, 2021


Questions for discussion:

  • What is motivating the firm to split itself into two companies at this time?
  • Do you think this is a good strategic decision for stockholders?
  • How do you think investors should deal with the choices – hold both companies, buy one, or sell?

Leave a Reply

Your email address will not be published. Required fields are marked *